Hedge Fund - Armistice Capital
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $116,334,639 | 1.38% | 820,240 | $144.87 |
| 2 | 2025 - Q3 (2025-09-30) | $97,847,948 | 1.45% | 697,022 | $135.50 |
| 3 | 2025 - Q2 (2025-06-30) | $84,969,457 | 1.47% | 676,024 | $114.68 |
| 4 | 2025 - Q1 (2025-03-31) | $110,621,014 | 1.66% | 1,000,190 | $126.68 |
| 5 | 2024 - Q4 (2024-12-31) | $121,758,000 | 1.66% | 892,000 | $123.68 |
| 6 | 2024 - Q3 (2024-09-30) | $20,898,719 | 0.33% | 181,381 | $137.09 |
| 7 | 2024 - Q2 (2024-06-30) | $134,708,443 | 1.69% | 978,488 | $137.14 |
| 8 | 2024 - Q1 (2024-03-31) | $141,194,083 | 1.87% | 1,023,739 | $136.57 |
| 9 | 2023 - Q4 (2023-12-31) | $138,084,480 | 1.88% | 1,048,000 | $115.11 |
| 10 | 2023 - Q3 (2023-09-30) | $136,841,063 | 2.09% | 1,216,365 | $105.30 |
| 11 | 2023 - Q2 (2023-06-30) | $155,595,000 | 2.25% | 1,650,000 | $97.71 |
| 12 | 2023 - Q1 (2023-03-31) | $161,142,240 | 2.32% | 1,592,000 | $104.06 |
| 13 | 2022 - Q4 (2022-12-31) | $107,496,000 | 1.87% | 900,000 | $117.13 |
| 14 | 2022 - Q3 (2022-09-30) | $140,622,000 | 2.43% | 1,324,000 | $101.46 |
| 15 | 2022 - Q2 (2022-06-30) | $129,064,000 | 2.25% | 1,324,000 | $92.29 |
| 16 | 2022 - Q1 (2022-03-31) | $60,938,000 | 1.17% | 650,000 | $84.75 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center